Library — CHDR

Search

Filter

Complement Activation in Inflammatory Skin Diseases.

Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP, Damman J

Frontiers in immunology, 2018 Jul

View publication
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.

van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA

Clinical and translational science, 2018 Jul

View publication
Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?

Veen C, Jacobs G, Philippens I, Vermetten E

Current topics in behavioral neurosciences, 2018 Jun

View publication
Futility of current urine salbutamol doping control.

Heuberger JAAC, van Dijkman SC, Cohen AF

British journal of clinical pharmacology, 2018 May

View publication
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1.

van Gerven J, Bonelli M

British journal of clinical pharmacology, 2018 May

View publication
The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer

van Meir H, du Burck IJ, de Kam ML, Welters MJP, van der Burg SH, Trimbos JBMZ, de Kroon CD, van Poelgeest MIE.

2018 May

View publication
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Reijers JAA, Kallend DG, Malone KE, Jukema JW, Wijngaard PLJ, Burggraaf J, Moerland M

Cardiovascular drugs and therapy, 2018 May; 31(4):381-389

View publication
A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds.

van Esdonk MJ, Burggraaf J, van der Graaf PH, Stevens J

Journal of pharmacokinetics and pharmacodynamics, 2018 May; 44(4):389-400

View publication
Respiratory Effects of the Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist, Cebranopadol, in Healthy Human Volunteers.

Dahan A, Boom M, Sarton E, Hay J, Groeneveld GJ, Neukirchen M, Bothmer J, Aarts L, Olofsen E

Anesthesiology, 2018 May; 126(4):697-707

View publication

«
1
2
3
4
5
6
7
8
...
58
59
»